Amplio Pharma now planning a phase 2a study after NovoBioJect raised intracellular active methotrexate levels by 38%.
|Articles|August 12, 2022
Rheumatoid Arthritis Quiz: Vaccinating Patients Taking Immunosuppressive Medications
Author(s)Ingrid Torjesen
Immunosuppressive medication can interfere with the immune response to vaccines, so treatment may need to be held or the timing or type of vaccinations amended. Test your knowledge of vaccinating rheumatoid arthritis patients taking immunosuppressive therapies in this quiz.
Advertisement
The American College of Rheumatology (ACR) recommends pneumococcal vaccination for patients taking immunosuppressive medication if they fall into which of the following age groups?
Advertisement
Related to this article
The EC approved upadacitinib for active polyarticular JIA in children 2 years and older, based on phase 1 SELECT-YOUTH efficacy and safety data.
August 2026 rheumatology highlights include FDA approval of brepocitinib for dermatomyositis and garetosmab-grts for FOP, and new trial data.
In RA-BRIDGE and RA-BRANCH, baricitinib failed to demonstrate VTE noninferiority in patients with RA enriched for thromboembolic risk factors.
A Phase 2a basket trial produced ACR50 responses in 71% of refractory RA patients at 6 months.
Advertisement
Advertisement